tiprankstipranks
Trending News
More News >
Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
US Market
Advertisement

Elite Pharmaceuticals (ELTP) Earnings Dates, Call Summary & Reports

Compare
362 Followers

Earnings Data

Report Date
Nov 18, 2025
TBA (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
Last Year’s EPS
-0.01
Same Quarter Last Year
Based on 1 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Jun 30, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue and profit growth, successful product launches, and a robust balance sheet. However, concerns were raised over non-cash derivative expenses affecting pretax income and earnings per share, alongside high competition in key markets.
Company Guidance
During the Elite Pharmaceuticals conference call, several key financial metrics and growth indicators were highlighted for the fiscal year ending March 31, 2025. The company reported total revenues of $84 million, marking a 52% increase from the previous year’s $56.6 million. This significant growth was attributed to the establishment of the Elite label in niche markets and the successful launch of the Lisdexamfetamine product line. Operating income rose to $19.6 million, reflecting an 82% increase from the prior year's $10.8 million. Despite a pretax loss of $52,000, due to a noncash expense of $18.9 million related to the change in fair value of derivatives, the company maintained a positive operating cash flow of $7.5 million, a notable improvement from the previous year's $3.2 million cash burn. Working capital increased by 41% to $45.9 million, underscoring a strengthening balance sheet with decreasing debt. The earnings per share (EPS) for the year was reported as 0, influenced by the aforementioned noncash derivative expense, compared to $0.02 in the previous year.
Record Revenue Growth
Total revenues for the 2025 fiscal year were $84 million, a $27.9 million increase or 52% over the prior year.
Significant Profit Increase
Operating income for 2025 was $19.6 million, an increase of 82% from the previous fiscal year.
Successful Product Launch
Launch of the Lisdexamfetamine product line in the last quarter contributed significantly to revenue growth, capturing about 8-10% of the market despite high competition.
Positive Cash Flow
Operating cash flow was positive at $7.5 million, compared to a $3.2 million cash burn the previous year, marking a $10.7 million swing to the positive.
Strengthened Balance Sheet
Working capital increased to $45.9 million from $27 million, and current liabilities decreased, indicating low and decreasing debt.

Elite Pharmaceuticals (ELTP) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ELTP Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Nov 18, 2025
2026 (Q2)
- / -
-0.01
Aug 14, 2025
2026 (Q1)
- / -
0.001
Jun 30, 2025
2025 (Q4)
- / >-0.01
0.001-700.00% (>-0.01)
Feb 13, 2025
2025 (Q3)
- / -0.01
0.001-1100.00% (-0.01)
Nov 14, 2024
2025 (Q2)
- / -0.01
0.015-166.67% (-0.03)
Aug 14, 2024
2025 (Q1)
- / -
0.001
Jul 01, 2024
2024 (Q4)
- / <0.01
0.0010.00% (0.00)
Feb 14, 2024
2024 (Q3)
- / <0.01
0.003-66.67% (>-0.01)
Nov 14, 2023
2024 (Q2)
- / 0.01
0.002650.00% (+0.01)
Aug 14, 2023
2024 (Q1)
- / <0.01
0
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ELTP Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 14, 2025
$0.53$0.530.00%
Jun 30, 2025
$0.73$0.67-8.22%
Feb 13, 2025
$0.55$0.53-3.64%
Nov 14, 2024
$0.52$0.56+7.69%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Elite Pharmaceuticals (ELTP) report earnings?
Elite Pharmaceuticals (ELTP) is schdueled to report earning on Nov 18, 2025, TBA (Confirmed).
    What is Elite Pharmaceuticals (ELTP) earnings time?
    Elite Pharmaceuticals (ELTP) earnings time is at Nov 18, 2025, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ELTP EPS forecast?
          Currently, no data Available
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis